Nine regions on six mouse autosomes are subject to imprinting and uniparental inheritance of any one of these regions results in mice with phenotypic anomalies. So far on distal Chromosome (Chr) 2 there is a unique imprinting region between 2H3 and 2H4 associated with two behavioural disorders and neonatal lethality. A maternally imprinted gene, Nnat, has been identified which is expressed in the nervous system and maps to distal Chr 2. Nnat has been excluded as a candidate for either or both the behavioural phenotypes as it lies proximal to the 2H3–2H4 imprinting region. Here we have mapped Nnat to band 2H1 which is at least 18 Mb proximal to the previously described imprinting region. It maps close to agouti, some alleles of which show differential expression according to parental origin. The localisation of Nnat to band H1 confirms and refines the map location of a second imprinting region on mouse Chr 2.

1.
Argeson AC, Nelson KK, Siracusa LD: Molecular basis of the pleiotropic phenotype of mice carrying hypervariable yellow (Ahvy) mutation at the agouti locus. Genetics 142:557–567 (1996).
2.
Beechey CV, Peters J: Dosage effects of the distal Chromosome 2 imprinting region. Mouse Genome 92:353–354 (1994).
3.
Beechey CV, Cattanach BM: Genetic and physical imprinting map of the mouse. Mouse Genome 95:100–105 (1997).
4.
Breen M, Deakin L, Macdonald B, Miller S, Tarttelin E, Avner P, Bourgade F, Guenet J-L, Montagutelli X, Poirier C, Simon D, Tailor D, Bishop M, Kelly M, Rysavy F, Rastan S, Norris D, Shepherd D, Abbott C, Pilz A, Hodge S, Jackson I, Boyd Y, Blair H, Maslen G, Todd J, Reed P, Stoye J, Ashworth A, McCarthy L, Cox R, Schalkwyk L, Lehrach H, Klose J, Gangadharan U, Brown S: Towards high resolution maps of the mouse and human genomes – a facility for ordering markers to 0.1 cM resolution. Hum mol Genet 3:621–627 (1994).
5.
Cattanach BM: Parental origin effects in mice. J Embryol exp Morph 97:137–150 (1986).
6.
Cattanach BM, Kirk M: Differential activity of maternally and paternally derived chromosome regions in mice. Nature 315:496–498 (1985).
7.
Cattanach BM, Beechey CV: Reassessment of the proximal Chr 2 imprinting lethality. Mouse Genome 93:858–859 (1995).
8.
Cattanach BM, Beechey CV, Evans EP, Burtenshaw M: Further localisation of the distal chromosome 2 imprinting region. Mouse Genome 89:255–256 (1991).
9.
Cattanach BM, Evans EP, Burtenshaw M, Beechey CV: Further delimitation of the distal Chromosome 2 imprinting region. Mouse Genome 90:82 (1992).
10.
Cattanach BM, Jones J: Genetic imprinting in the mouse: implications for gene regulation. J Inherit Metab Dis 17:403–420 (1994).
11.
de Boer P, van Gijsen M: The location of the positions of the breakpoints involved in the T26H and T70H mouse translocations with the aid of Giemsa-banding. Can J Genet Cytol 16:783–788 (1974).
12.
Dietrich W, Katz H, Lincoln SE, Shin H-S, Friedman J, Dracopoli NC, Lander ES: A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131:423–447 (1992).
13.
Dou D, Joseph R: Cloning of human neuronatin gene and its localization to chromosome-20q11.2→q12: the deduced protein is a novel “proteolipid”. Brain Res 723:8–22 (1996).
14.
Eicher EM, Washburn LL: Assignment of genes to regions of mouse chromosomes. Proc natl Acad Sci, USA 75:946–950 (1978).
15.
Evans EP, Burtenshaw M: T(2;4)1Sn. Revised banding breakpoints. Mouse News Lett 81:66 (1988).
16.
Ford CE: The use of chromosome markers, in Micklen HS, Loutit JF (eds): Appendix in Tissue Grafting and Radiation, pp 197–206 (Academic Press, New York 1966).
17.
Grüneberg H, Lee AJ: The anatomy and development of brachypodism in the mouse. J Embryol exp Morphol 30:119–141 (1973).
18.
Joseph R, Dou D, Tsang W: Molecular cloning of a novel mRNA (neuronatin) that is highly expressed in neonatal mammalian brain. Biochem biophys Res Commun 201:1227–1234 (1994).
19.
Kagitani F, Kuroiwa Y, Wakana S, Shiroishi T, Miyoshi N, Kobayashi S, Nishida M, Kohda T, Kaneko-Ishino T, Ishino F: Peg5/Neuronatin is an imprinted gene located on sub-distal chromosome 2 in the mouse. Nucl Acids Res 25:3428–3432 (1997).
20.
Kikyo N, Williamson CM, John RM, Barton SC, Beechey CV, Ball ST, Cattanach BM, Surani MA, Peters J: Genetic and functional analysis of neuronatin in mice with maternal or paternal duplication of distal Chr 2. Dev Biol 190:66–77 (1997).
21.
Konecki DS, Brennand J, Fuscoe JC, Caskey CT, Chinault AC: Hypoxanthine-guanine phosphoribosyltransferase genes of the mouse and Chinese hamster: construction and sequence analysis of cDNA recombinants.Nucl Acids Res 10:6763–6775 (1982).
22.
Lalande M: Parental imprinting and human disease. A Rev Genet 30:173–195 (1997).
23.
Lam EW, Robinson C, Watson RJ: Characterization and cell cycle-regulated expression of mouse B-myb. Oncogene 7:1885–1890 (1992).
24.
Michaud EJ, van Vugt MJ, Bultman SJ, Sweet HO, Davisson MT, Woychik RP: Differential expression of a new dominant agouti allele (Aiapy) is correlated with methylation state and is influenced by parental lineage.Genes Dev 8:1463–1472 (1994).
25.
Nelson KK, Knopf JL, Siracusa LD: Localization of phospholipase C-1 to mouse Chromosome 2. Mammal Genome 3:597–600 (1992).
26.
Noben-Trauth K, Copeland NG, Gilbert DJ, Jenkins NA, Sonoda G, Testa JR, Klempnauer K-H: Mybl2 (Bmyb) maps to mouse Chromosome 2 and human chromosome 20q13.1. Genomics 35:610–612 (1996).
27.
Peters J, Beechey CV, Ball ST, Evans EP: Mapping studies of the distal imprinting region of mouse Chromosome 2. Genet Res 63:169–174 (1994).
28.
Searle AG, Beechey CV: Complementation studies with mouse translocations. Cytogenet Cell Genet 20:282–303 (1978).
29.
Searle AG, Ford CE, Beechey CV: Meiotic disjunction in mouse translocations and the determination of centromere position. Genet Res 18:215–235 (1971).
30.
Snell GD: An analysis of translocations in the mouse. Genetics 31:157–180 (1946).
31.
Solter D: Differential imprinting and expression of maternal and paternal genomes. A Rev Genet 22:127–146 (1988).
32.
Stahl ML, Ferenz CR, Kelleher KL, Kriz RW, Knopf JL: Sequence similarity of phospholipase C with the non-catalytic region of src. Nature 332:269–272 (1988).
33.
Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee S-J: Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily. Nature 368:639–643 (1994).
34.
Surani MA: Genomic imprinting: developmental significance and molecular mechanism. Curr Opin Genet Dev 1:241–246 (1994).
35.
Wijnholds J, Chowdhury K, Wehr R, Gruss P: Segment specific expression of the neuronatin gene during early hindbrain development. Dev Biol 171:73–84 (1995).
36.
Williamson CM, Dutton ER, Beechey CV, Peters J: Protective protein for β-galactosidase, Ppgb, maps to the distal imprinting region of mouse chromosome 2 but is not imprinted. Genomics 22:240–242 (1994).
37.
Williamson CM, Miller HJ, Beechey CV, Peters J: Microsatellite marker D2Mit226 for the identification of duplication/deficient mice for the distal region of Chr 2. Mouse Genome 93:860 (1995).
38.
Williamson CM, Dutton ER, Abbott CM, Beechey CV, Ball ST, Peters J: Thirteen genes (Cebpb, E2f1, Tcf4, Cyp24, Pck1, Acra4, Edn3, Kcnb1, Mc3r, Ntsr, Cd40, Plcg1 and Rcad) that probably lie in the distal imprinting region of mouse Chromosome 2 are not monoallelically expressed. Genet Res 65:83–93 (1995).
39.
Wolf GL: Influence of maternal phenotype on metabolic differentiation of agouti locus mutants in the mouse. Genetics 88:529–539 (1978).
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.